Latest news and press releases about Fonar Corp. (FONR): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services.
Price
| Price | $19.09 |
| Market Cap | $118M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| P/E Ratio | 18.90 |
| Price / Book | 0.66 |
| EV / EBITDA | 6.47 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | 3.81% |
| Return on Invested Capital | 3.59% |
| Return on Assets | 3.05% |
| Gross Margin | 40.26% |
| Operating Margin | 9.05% |
| Net Margin | 6.35% |
Related companies: APYX · ARTV · EDAP · HYPR · IFRX · LUNG · NSPR
Explore sector: Healthcare · Medical - Equipment & Services
More sections of FONR: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks